Abstract: The invention is to methods for identifying asymptomatic patients who have a likelihood of benefiting from administration of an estrogen activity modulator for risk reduction or therapeutic treatment of breast cancer, methods for reducing risk or therapeutically treating these asymptomatic patients, and methods for monitoring the treatments.
Type:
Application
Filed:
June 30, 2003
Publication date:
May 13, 2004
Applicants:
Cytyc Health Corporation, WINDY HILL TECHNOLOGY, INC. A Delaware Corporation